Evidence map›Paper›PMID 37333050›Full record

ArticleSustainable chemistry and pharmacy2023

Green and rapid and instrumental one-pot method for the synthesis of imidazolines having potential anti-SARS-CoV-2 main protease activity.

Sabikeh Azimi, Muna S Merza, Fatemeh Ghasemi, Hasan Ali Dhahi, Farid Baradarbarjastehbaf, Mehdi Moosavi, Pouya Ghamari Kargar, Christophe Len

RetractedOpen access · greenAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Sustainable chemistry and pharmacy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 4 countries.

Sabikeh AzimiDepartment of Chemistry, Faculty of Sciences, University of Birjand, Birjand, 97175-615, Iran.
Muna S MerzaProsthetic Dental Techniques Department, Al-Mustaqbal University College, Babylon, 51001, Iraq.
Fatemeh GhasemiMSC in Software Engineering, Kowsar, The Institute of Higher Education, Ministry of Science, Research and Technology, Computer Engineering Department, Qazvin, Iran.
Hasan Ali DhahiNational University of Science and Technology, Dhi Qar, Iraq.
Farid BaradarbarjastehbafFaculty of Pharmacy, Department of Pharmaceutical Technology and Biopharmacy, University of Pécs, Pécs, Hungary.
Mehdi MoosaviDepartment of Chemistry, Faculty of Chemistry, Mazandaran University, Babolsar, Iran.
Pouya Ghamari KargarDepartment of Chemistry, Faculty of Sciences, University of Birjand, Birjand, 97175-615, Iran.
Christophe LenChimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, 11 Rue Pierre et Marie Curie, F-75005, Paris, France.
University of Birjand · IRMinistry of Science, Research and Technology · IRThi Qar University · IQUniversité Paris Sciences et Lettres · FRUniversity of Mazandaran · IRUniversity of Pecs · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) is responsible for ongoing epidemics in humans and some other mammals and has been declared a public health emergency of international concern. In this project, several small non-peptide molecules were synthesized to inhibit the major proteinase (M

Indexed as

ImidazolinesIn-silico studiesN-Bromosaccharin (NBSac)SARS-CoV-2) Mpro

Identifiers

PMID37333050
PMCPMC10239909
OpenAlexW4379387722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.